Brief: New Nordic Healthbrands Q4 EBITDA Loss Widens To SEK 6.0 Mln
Feb 28 (Reuters) - New Nordic Healthbrands AB NWND.ST :
* Q4 NET SALES AMOUNTED TO MSEK 111.7 (121.0)
* Q4 EBITDA DECREASED TO MSEK -6.0 (-4.0)
* NEW NORDIC HEALTHBRANDS AB - BOARD HAS AGREED TO PROPOSE
TO
ANNUAL GENERAL MEETING THAT WE WILL NOT PAY OUT ANY DIVIDEND FOR
2022
Source text for Eikon: ID:nBQN3g0nzF
Further company coverage: NWND.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on New Nordic Healthbrands AB
See all newsBrief: New Nordic Healthbrands AB Q1 Group's Net Sales In Sek Decreased By 7.9% To Sek 132.5 Million
Brief: New Nordic Healthbrands Q4 Operating Profit Up At SEK 3.7 Mln
Brief: New Nordic Healthbrands Q3 Operating Profit SEK 2.7 Mln
Brief: New Nordic Healthbrands Q2 Net Sales Up At SEK 143.0 Mln
Brief: New Nordic Healthbrands Elects Kirsten Ægidius Chairman Of Board